Changes in body composition at menopause - Age, lifestyle or hormone deficiency?

Journal of the British Menopause Society

Volumn 8, Issue 4, 2002, Pages 137-140

  Sørensen, Morten B ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Adipose tissue; Lean body mass; Menopause; Obesity; Oestrogen

Indexed keywords

ANDROGEN; DIGOXIN; ESTROGEN; HORMONE; LEPTIN; SEX HORMONE; TESTOSTERONE; THEOPHYLLINE;

ABDOMEN; ADIPOSE TISSUE; AGE; BODY COMPOSITION; BONE MINERAL; CLIMACTERIUM; CLINICAL TRIAL; DRUG MECHANISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEALTH HAZARD; HEALTH PROGRAM; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LEAN BODY WEIGHT; LIFESTYLE; LONG TERM CARE; MENOPAUSE; MOTIVATION; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; OBESITY; PATIENT ATTITUDE; POSTMENOPAUSE; REVIEW; SHORT COURSE THERAPY; SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0036951604     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/136218002100321974     Document Type: Review

References (48)

1. Meema S, Reid DB, Meema HE. Age trends of bone mineral mass, muscle width, and subcutaneous fat in normals and osteoporotics. Calcif Tissue Res 1973; 12: 101-112.
2. Hassager C, Gotfredsen A, Jensen J, Christiansen C. Prediction of body composition by age, height, weight, and skinfold thickness in normal adults. Metabolism 1986; 35: 1081-1084.
3. Kyle UG, Gremion G, Genton L, et al. Physical activity and fat-free and fat mass by bioelectrical impedance in 3853 adults. Med Sci Sports Exerc 2001; 33: 576-584.
4. Morley JE. Decreased food intake with aging. J Gerontol A Biol Sci Med Sci 2001; 56 (Spec No 2): 81-88.
5. Morley JE. Anorexia, sarcopenia and aging. Nutrition 2001; 17: 660-663.
6. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
7. Ainslie DA, Morris MJ, Wittert G, et al. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 2001; 25: 1680-88.
8. Baumgartner RN, Ross RR, Waters DL, et al. Serum leptin in elderly people: Associations with sex hormones, insulin, and adipose tissue volumes. Obes Res 1999; 7: 141-149.
9. Jones ME, Thorburn AW, Britt KL, et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 2000; 97: 12735-12740.
10. Rosenfalck AM, Almdal T, Gotfredsen A, Hilsted J. Body composition in normal subjects: Relation to lipid and glucose variables. Int J Obes Relat Metab Disord 1996; 20: 1006-1013.
11. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995; 273: 199-208.
12. Kristensen K, Pedersen SB, Vestergaard P, et al. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J Endocrinol 1999; 163: 55-62.
13. Sørensen MB, Rosenflack AM, Højgaard L, Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res 2001; 9: 622-626.
14. Legare F, Godin G, Guilbert E, et al. Determinants of the intention to adopt hormone replacement therapy among premenopausal women. Maturitas 2000; 34: 211-218.
15. Norman RJ, Flight IH, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and postmenopausal women: Weight and body fat distribution. Cochrane Database Syst Rev 2000: CD001018.
16. Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 1992; 55: 950-54.
17. Zborowski JV, Talbott EO, Cauley JA. Polycystic ovary syndrome, androgen excess, and the impact on bone. Obstet Gynecol Clin North Am 2001; 28: 135-151.
18. Tremollieres FA, Pouilles JM, Ribot CA. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol 1996; 175: 1594-1600.
19. Panotopoulos G, Ruiz JC, Raison J et al. Menopause, fat and lean distribution in obese women. Maturitas 1996; 25: 11-19.
20. Haarbo J, Marslew U, Gotfredsen A, et al. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991; 40: 1323-1326.
21. Reubinoff BE, Wurtman J, Rojansky N, Adler D, et al. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: A prospective study. Fertil Steril 1995; 64: 963-968.
22. Smith MR, Finkelstein JS, McGovern FJ, et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 2002; 87: 599-603.
23. Samaras K, Kelly PJ, Spector TD, et al. Tobacco smoking and oestrogen replacement are associated with lower total and central fat in monozygotic twins. Int J Obes Relat Metab Disord 1998; 22: 149-156.
24. Dionne IJ, Kinaman KA, Poehlman ET. Sarcopenia and muscle function during menopause and hormone-replacement therapy. J Nutr Health Aging 2000; 4: 156-161.
25. Davis SR, Walker KZ, Strauss BJ. Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women. Menopause 2000; 7: 395-401.
26. Dobs AS, Nguyen T, Pace C, Roberts CP. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 2002; 87: 1509-1516
27. Lovejoy JC, Bray GA, Bourgeois MO et al. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women - A clinical research center study. J Clin Endocrinol Metab 1996; 81: 2198-2203.
28. Parra A, Cervantes C, Sanchez M, et al. The relationship of plasma gonadotrophins and steroid concentrations to body growth in girls. Acta Endocrinol 1981, 98: 161-170.
29. Hartmann B, Kirchengast S, Albrecht A, et al. Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women. Maturitas 1995; 22: 239-246.
30. Sarwar R, Niclos BB, Rutherford OM. Changes in muscle strength, relaxation rate and fatiguability during the human menstrual cycle. J Physiol 1996; 493: 267-272.
31. Skelton DA, Phillips SK, et al. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in postmenopausal women. Clin Sci 1999; 96: 357-364.
32. Jensen J, Christiansen C, Rodbro P. Oestrogen-progestegen replacement therapy changes body composition in early postmenopausal women. Maturitas 1986; 8: 209-216.
33. Reubinoff BE, Wurtman J, Rojansky N, et al. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: A prospective study. Fertil Steril 1995; 64: 963-968.
34. Sørensen MB, Fritz-Hansen T, Jensen HH, et al. Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement. Am J Obstet Gynecol 2001; 184: 414-7.
35. Haarbo J, Gotfredsen A, Hassager C, Christiansen C. Validation of body composition by dual energy X-ray absorptiometry (DEXA). Clin Physiol 1991; 11: 331-341.
36. Writing group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-33.
37. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677-685.
38. Spencer CP, Godsland IF, Stevenson JC. Is there a menopausal metabolic syndrome? Gynecol Endocrinol 1997; 11: 341-355.
39. Lapidus L, Bengtsson C, Larsson B, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984; 289: 1257-1261.
40. Kannel WB, Cupples LA, Ramaswami R, et al. Regional obesity and risk of cardiovascular disease; The Framingham Study. J Clin Epidemiol 1991; 44: 183-190.
41. Hurley BF, Roth SM. Strength training in the elderly: Effects on risk factors for age-related diseases. Sports Med 2000; 30: 249-268.
42. Madsen KL, Adams WC. Effects of physical activity, body weight and composition, and muscular strength on bone density in young men. Med Sci Sports Exerc 1998; 30: 114-120.
43. Lazarus R, Sparrow D, Weiss ST. Handgrip strength and insulin levels: Cross-sectional and prospective associations in the Normative Ageing Study. Metabolism 1997; 46: 1266-1269.
44. Jensen GF, Christiansen C, Boesen J, et al. Relationship between bone mineral content and frequency of postmenopausal fractures. Acta Med Scand 1983; 213: 61-63.
45. Sheu WH, Jeng CY, Young MS, et al. Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes. Am J Med Sci 2000; 319: 84-88.
46. Brooke-Wavell K, Prelevic GM, Bakridan C, Ginsburg J. Effects of physical activity and menopausal hormone replacement therapy on postural stability in postmenopausal women - A cross-sectional study. Maturitas 2001; 37: 167-172.
47. Barengolts EI, Berman M, Kukreja SC, et al. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 1998; 62: 209-213.
48. Kuller LH, Simkin-Silverman LR, Wing RR et al. Women's Healthy Lifestyle Project: A randomized clinical trial: Results at 54 months. Circulation 2001; 103: 32-37.